CAR-T cell therapies Market Research Methodology, Competitive Analysis and Estimation Forecast by 2028
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
CAR T cell therapy is a complex process that should be done by experts with extensive experience.
The process takes a few weeks, and the steps generally include:
• 𝗖𝗼𝗹𝗹𝗲𝗰𝘁𝗶𝗻𝗴 𝗧 𝗰𝗲𝗹𝗹𝘀: We draw blood from a vein in your arm. The blood flows through a tube into an apheresis machine, which removes T cells. The machine returns the rest of the blood back into your body through a different tube.
• 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗧 𝗰𝗲𝗹𝗹𝘀: In a laboratory, scientists engineer the T cells by adding a manufactured CAR. Then the lab lets the CAR T cells multiply and grow.
• 𝗜𝗻𝗳𝘂𝘀𝗶𝗻𝗴 𝗖𝗔𝗥 𝗧 𝗰𝗲𝗹𝗹𝘀: Once the lab has enough CAR T cells, we inject them back into your arm. Your healthcare team might recommend chemotherapy before the CAR T cell infusion to help boost the treatment’s effectiveness.
0
